Influences on Human Papillomavirus Vaccination Status Among Female College Students

Daley, Ellen M.; Vamos, Cheryl A.; Buhi, Eric R.; Kolar, Stephanie K.; McDermott, Robert J.; Hernandez, Natalie; Fuhrmann, Hollie J.

doi:10.1089/jwh.2009.1861

Cited by 71 publications

(38 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our findings are in agreement with published literature that have shown adolescents' acceptance of a vaccine is associated with their parents' attitude toward the vaccine, and their perception that parents felt the vaccine is efficient and safe. 24,25 In addition, a primary predictor to HPV vaccine uptake might be generalizable to other settings in Germany, where uptake of other vaccines e.g., against tetanus and measles is usually not a major problem as also indicated in our study. The German Health Interview and Examination Survey for Children and Adolescents (KiGGS) from 2007 showed a significant difference in vaccination coverage for basic immunization such as tetanus, diphtheria and poliomyelitis among students with and without migration background.…”

Section: Discussionsupporting

confidence: 59%

Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010

Stöcker

Dehnert

Schuster

et al. 2013

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

IntroductionPersisting human papillomavirus (HPV) infections, especially with HPV high-risk types 16 or 18, are prerequisites for cervical precancer and cancer. At the end of 2006 a quadrivalent HPV-vaccine became available in Germany providing protection against the HPV-types 6, 11, 16, and 18. The primary vaccination series consists of 3 separate doses administered at 0, 2, and 6 mo. If an alternate vaccination schedule is necessary, the second dose should be administered at least one month after the first and the third at least 3 mo after the second dose. The primary vaccination series should be completed within a 1-y period, according to the German summary of product characteristics (SPC). In 2007, a bivalent vaccine was approved for immunisation against HPV-types 16 and 18. For this vaccine, the German SPC recommends a vaccination schedule of 0, 1, 6 mo. HPV vaccination is free of charge in Germany. In clinical trials, the HPV-vaccines demonstrated > 90% efficacy against HPV 16-and 18-related Purpose: since March 2007, the standing committee on Vaccination (sTIKO) recommends HpV vaccination for all 12-17 y-old females in Germany. In the absence of an immunization register, we aimed at assessing HpV-vaccination coverage and knowledge among students in Berlin, the largest city in Germany, to identify factors influencing HpV-vaccine uptake.Results: Between september and December 2010, 442 students completed the questionnaire (mean age 15.1; range 14-19). In total 281/442 (63.6%) students specified HpV correctly as a sexually transmitted infection. Of 238 participating girls, 161 (67.6%) provided their vaccination records. among these, 66 (41.0%) had received the recommended three HpVvaccine doses. Reasons for being HpV-unvaccinated were reported by 65 girls: Dissuasion from parents (40.2%), dissuasion from their physician (18.5%), and concerns about side-effects (30.8%) (multiple choices possible). The odds of being vaccinated increased with age [Odds Ratio (OR) 2.19, 95% confidence Interval (cI) 1.16, 4.15] and decreased with negative attitude toward vaccinations (OR = 0.33, 95% cI 0.13, 0.84).Methods: self-administered questionnaires were distributed to 10th grade school students in 14 participating schools in Berlin to assess socio-demographic characteristics, knowledge, and statements on vaccinations. Vaccination records were reviewed. Multivariable statistical methods were applied to identify independent predictors for HpV-vaccine uptake among female participants.Conclusions: HpV-vaccine uptake was low among school girls in Berlin. Both, physicians and parents were influential regarding their HpV-vaccination decision even though personal perceptions played an important role as well. school programs could be beneficial to improve knowledge related to HpV and vaccines, and to offer low-barrier access to HpV vaccination.Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010 In Germany, a structured program for the evaluation and assessment of the impact...

show abstract

Section: Discussionsupporting

confidence: 59%

Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010

Stöcker

Dehnert

Schuster

et al. 2013

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

“…12 In our sample, women who had been vaccinated had a higher level of knowledge (OR 1.83 95% CI 1.57-2.14) and this result is consistent with previous reports. 2,19 Possible explanations for this association could include: those who are vaccinated engage in more preventive behaviors, receive more information from health providers, and as a result, have higher levels of knowledge about health.…”

mentioning

confidence: 99%

Knowledge of the HPV vaccine and its association with vaccine uptake among female higher-education students in Greece

Donadiki

Jiménez‐García²,

Hernández-Barrera³

et al. 2013

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

“…A cursory overview of the literature regarding HPV vaccination indicates that more extensive efforts have been made to evaluate female attitudes, acceptance, and intent to receive HPV vaccination [13]. For instance, Conroy et al [14] examined predictors and barriers to HPV vaccination among women.…”

Section: Hpv Vaccination Attitudes Of Males and Femalesmentioning

confidence: 99%

HPV Vaccination and the Controversy and Attitudes of Male and Female College Students

Johnson¹

2017

Health Sci J

View full text Add to dashboard Cite

In recent years, the development of the Human Papillomavirus (HPV) vaccines have spurred controversy over whether or not males as well as females should obtain the vaccine against the HPV disease. HPV vaccination is an important public health issue because it prevents cancer. The HPV vaccination reduces rates of transmission of genital warts and certain HPV related cancers in males as well as reducing the incidence of cervical cancer in women. The development of the HPV vaccine has further improved opportunities for healthcare providers to effectively combat the human papillomavirus disease. Presently, there are three vaccines marketed in the United States and approved by the FDA that can protect against the sexually transmitted infection of HPV. They are Gardasil®, Gardasil 9®, Cervarix®. All three prevent infections with HPV types 16 and 18, which are the two highest risk that cause approximately 70% of cervical cancer in women and a higher percentage of other HPV-related cancers in men and women. In this article the researcher will focus on the three Human Papillomavirus vaccines, controversy over the HPV vaccine and attitudes of male and female college students regarding the HPV vaccine.

show abstract

Influences on Human Papillomavirus Vaccination Status Among Female College Students

Abstract: Findings suggest that healthcare providers have an important role in encouraging HPV vaccination. Continuing education for providers who see preadolescent girls in conjunction with a parent or who treat women of college age may be a worthwhile endeavor.

Cited by 71 publications

References 17 publications

Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010

Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010

Knowledge of the HPV vaccine and its association with vaccine uptake among female higher-education students in Greece

HPV Vaccination and the Controversy and Attitudes of Male and Female College Students

Contact Info

Product

Resources

About